Cognitive impairment after sepsis is an important clinical problem. Determinants of postseptic cognitive impairment are not well understood. We thus undertook a systems biology approach to exploring a possible role for apolipoprotein E (APOE) in postseptic cognitive impairment.
Design:
Prospective, observational cohort.
Setting:
Intermountain Medical Center, a tertiary referral center in Utah.
Patients/Participants:
Patients with sepsis admitted to study intensive care units.
Interventions:
None.
Methods:
We obtained peripheral blood for deep sequencing of RNA and followed up survivors at 6 months with a battery of cognitive instruments. We defined cognitive impairment based on the 6-month Hayling test of executive function. In our primary analysis, we employed weighted network analysis. Secondarily, we compared variation in gene expression between patients with normal versus impaired cognition.
Measurements and Main Results:
We enrolled 40 patients, of whom 34 were follow-up eligible and 31 (91%) completed follow-up; 1 patient’s RNA sample was degraded—the final analytic cohort was 30 patients. Mean Hayling test score was 5.8 (standard deviation 1.1), which represented 20% with impaired executive function. The network module containing APOE was dominated by low-expression genes, with no association on primary analysis (P = .8). Secondary analyses suggested several potential lines of future investigation, including oxidative stress.
Conclusions:
In this prospective pilot cohort, executive dysfunction affected 1 in 5 survivors of sepsis. The APOE gene was sparsely transcribed in peripheral leukocytes and not associated with cognitive impairment. Future lines of research are suggested.
SingerMDeutschmanCSSeymourCW, et al.The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801–810.
2.
ZimmermanJEKramerAAKnausWA. Changes in hospital mortality for United States intensive care unit admissions from 1988 to 2012. Crit Care. 2013;17(2):R81.
3.
NeedhamDMDavidsonJCohenH, et al.Improving long-term outcomes after discharge from intensive care unit: report from a stakeholders’ conference. Crit Care Med. 2012;40(2):502–509.
4.
BozzaFAGarteiserPOliveiraMF, et al.Sepsis-associated encephalopathy: a magnetic resonance imaging and spectroscopy study. J Cereb Blood Flow Metab. 2010;30(2):440–448.
5.
SharsharTAnnaneDDe GrandmaisonGLBroulandJPHopkinsonNSFrançoiseG. The neuropathology of septic shock. Brain Pathol. 2004;14(1):21–33.
6.
GirardTDJacksonJCPandharipandePP, et al.Delirium as a predictor of long-term cognitive impairment in survivors of critical illness. Crit Care Med. 2010;38(7):1513–1520.
7.
InouyeSKRushingJTForemanMDPalmerRMPompeiP. Does delirium contribute to poor hospital outcomes? A three-site epidemiologic study. J Gen Intern Med. 1998;13(4):234–242.
8.
PolitoAEischwaldFMahoAL, et al.Pattern of brain injury in the acute setting of human septic shock. Crit Care. 2013;17(5):R204.
9.
SemmlerAOkullaTSastreMDumitrescu-OzimekLHenekaMT. Systemic inflammation induces apoptosis with variable vulnerability of different brain regions. J Chem Neuroanat. 2005;30(2-3):144–157.
10.
Aguero-TorresHvon StraussEViitanenM, et al.Institutionalization in the elderly: the role of chronic diseases and dementia. cross-sectional and longitudinal data from a population-based study. J Clin Epidemiol. 2001;54(8):795–801.
11.
ChodoshJSeemanTEKeelerE, et al.Cognitive decline in high-functioning older persons is associated with an increased risk of hospitalization. J Am Geriatr Soc. 2004;52(9):1456–1462.
12.
NormanBCJacksonJCGravesJA, et al.Employment outcomes after critical illness: an analysis of the bringing to light the risk factors and incidence of neuropsychological dysfunction in ICU survivors cohort. Crit Care Med. 2016;44(11):2003–2009.
13.
SonnevilleRVerdonkFRauturierC, et al.Understanding brain dysfunction in sepsis. Ann Intens Care. 2013;3(1):15.
14.
CalsavaraAJCCostaPANobreV, et al.Factors associated with short and long term cognitive changes in patients with sepsis. Sci Rep. 2018;8(1):4509.
15.
MikkelsenMEChristieJDLankenPN, et al.The adult respiratory distress syndrome cognitive outcomes study: long-term neuropsychological function in survivors of acute lung injury. Am J Respir Crit Care Med. 2012;185(12):1307–1315.
16.
HopkinsROWeaverLKCollingridgeD, et al.Two-year cognitive, emotional, and quality-of-life outcomes in acute respiratory distress syndrome. Am J Respir Crit Care Med. 2005;171(4):340–347.
17.
JacksonJCGirardTDGordonSM, et al.Long-term cognitive and psychological outcomes in the awakening and breathing controlled trial. Am J Respir Crit Care Med. 2010;182(2):183–191.
18.
PorhomayonJJoudePAdlparvarGEl-SolhAANaderND. The impact of high versus low sedation dosing strategy on cognitive dysfunction in survivors of intensive care units: a systematic review and meta-analysis. J Cardiovasc Thorac Res. 2015;7(2):43–48.
19.
MorandiAHughesCGGirardTD, et al.Statins and brain dysfunction: a hypothesis to reduce the burden of cognitive impairment in patients who are critically ill. Chest. 2011;140(3):580–585.
20.
KhandakerGMJonesPB. Cognitive and functional impairment after severe sepsis. JAMA. 2011;305(7):673–674; author reply 674.
21.
LiKChingDLukFSRaffaiRL. Apolipoprotein E enhances microRNA-146a in monocytes and macrophages to suppress nuclear factor-kappaB-driven inflammation and atherosclerosis. Circ Res. 2015;117(1):e1–e11.
22.
TruscaVGFuiorEVFloreaICKardassisDSimionescuMGafencuAV. Macrophage-specific up-regulation of apolipoprotein E gene expression by STAT1 is achieved via long range genomic interactions. J Biol Chem. 2011;286(16):13891–13904.
23.
SalomonRNUnderwoodRDoyleMV, et al.Increased apolipoprotein E and c-fms gene expression without elevated interleukin 1 or 6 mRNA levels indicates selective activation of macrophage functions in advanced human atheroma. Proceed Nat Acad Sci. 1992;89(7):2814–2818.
24.
FukumotoHIngelssonMGarevikN, et al.APOE epsilon 3/ epsilon 4 heterozygotes have an elevated proportion of apolipoprotein E4 in cerebrospinal fluid relative to plasma, independent of Alzheimer’s disease diagnosis. Exp Neurol. 2003;183(1):249–253.
25.
LambertJCMannDRichardF, et al.Is there a relation between APOE expression and brain amyloid load in Alzheimer’s disease?J Neurol Neurosurg Psychiatry. 2005;76(7):928–933.
26.
Martinez-LopezENuno-GonzalezPRuiz-MadrigalB, et al.Apolipoprotein AI and apolipoprotein E mRNA expression in peripheral white blood cells from patients with orthotopic liver transplantation. Liver Int. 2007;27(7):930–937.
27.
BrownSMCollingridgeDSWilsonEL, et al.Preliminary validation of the montreal cognitive assessment tool among sepsis survivors: a prospective pilot study. Ann Ame Thor Soci. 2018;15(9):1108–1110.
28.
JormAF. The informant questionnaire on cognitive decline in the elderly (IQCODE): a review. Int Psychogeriatr. 2004;16(3):275–293.
29.
LezakMD. Neuropsychological Assessment. NY: Oxford University Press; 1995.
30.
SukantaratKTBurgessPWWilliamsonRCBrettSJ. Prolonged cognitive dysfunction in survivors of critical illness. Anaesthesia. 2005;60(9):847–853.
31.
BoylePAPaulRHMoserDJ, et al.Executive impairments predict functional declines in vascular dementia. Clin Neuropsychol. 2004;18(1):75–82.
32.
DugganMCWangLWilsonJEDittusRSElyEWJacksonJC. The relationship between executive dysfunction, depression, and mental health-related quality of life in survivors of critical illness: results from the BRAIN-ICU investigation. J Crit Care. 2017;37:72–79.
33.
PandharipandePPGirardTDJacksonJC, et al.Long-term cognitive impairment after critical illness. New England J Med. 2013;369(14):1306–1316.
34.
DobinADavisCASchlesingerF, et al.STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15–21.
35.
LiaoYSmythGKShiW. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30(7):923–930.
36.
LoveMIHuberWAndersS. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.
37.
HorvathS. Weighted Network Analysis: Applications in Genomics and Systems Biology. Berlin, Germany: Springer; 2011.
38.
BenjaminiYHochbergY. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Statist Soci Series B (Methodological). 1995;57(1):289–300.
39.
R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2009.
40.
MillerRR3rdDongLNelsonNC, et al.Multicenter implementation of a severe sepsis and septic shock treatment bundle. Am J Respir Crit Care Med. 2013;188(1):77–82.
41.
DinglasVDHopkinsROWozniakAW, et al.One-year outcomes of rosuvastatin versus placebo in sepsis-associated acute respiratory distress syndrome: prospective follow-up of SAILS randomised trial. Thorax. 2016;71(5):401–410.
SubramanianATamayoPMoothaVK, et al.Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545–15550.
44.
RaymondSLLopezMCBakerHV, et al.Unique transcriptomic response to sepsis is observed among patients of different age groups. PLoS One. 2017;12(9):e0184159.
45.
MlinaricAHorvatMSupak SmolcicV. Dealing with the positive publication bias: why you should really publish your negative results. Biochem Med (Zagreb). 2017;27(3):030201.
46.
JooberRSchmitzNAnnableLBoksaP. Publication bias: what are the challenges and can they be overcome?J Psychiatry Neurosci. 2012;37(3):149–152.
YiDLeeDYSohnBK, et al.Beta-amyloid associated differential effects of APOE epsilon4 on brain metabolism in cognitively normal elderly. Am J Geriatr Psychiatry. 2014;22(10):961–970.
49.
OssenkoppeleRvan der FlierWMZwanMD, et al.Differential effect of APOE genotype on amyloid load and glucose metabolism in AD dementia. Neurology. 2013;80(4):359–365.
50.
FriedmanGFroomPSazbonL, et al.Apolipoprotein E-epsilon4 genotype predicts a poor outcome in survivors of traumatic brain injury. Neurology. 1999;52(2):244–248.
51.
MoranLMTaylorHGGanesalingamK, et al.Apolipoprotein E4 as a predictor of outcomes in pediatric mild traumatic brain injury. J Neurot. 2009;26(9):1489–1495.
52.
ChamelianLReisMFeinsteinA. Six-month recovery from mild to moderate traumatic brain injury: the role of APOE-epsilon4 allele. Brain J Neurol. 2004;127(Pt 12):2621–2628.
53.
NathooNChetryRvan DellenJRConnollyCNaidooR. Apolipoprotein E polymorphism and outcome after closed traumatic brain injury: influence of ethnic and regional differences. J Neurosurg. 2003;98(2):302–306.
54.
HopkinsROWeaverLKValentineKJMowerCChurchillSCarlquistJ. Apolipoprotein E genotype and response of carbon monoxide poisoning to hyperbaric oxygen treatment. Am J Respir Crit Care Med. 2007;176(10):1001–1006.
55.
ElyEWGirardTDShintaniAK, et al.Apolipoprotein E4 polymorphism as a genetic predisposition to delirium in critically ill patients. Crit Care Med. 2007;35(1):112–117.
56.
HonmaTTsudukiTSugawaraS, et al.Aging decreases antioxidant effects and increases lipid peroxidation in the apolipoprotein E deficient mouse. J Clin Biochem Nutr. 2013;52(3):234–240.
57.
TacconeFSScollettaSFranchiF, et al.Brain perfusion in sepsis. Curr Vasc Pharmacol. 2013;11(2):170–186.
58.
FuPWangAMHeLYSongJMXueJCWangCQ. Elevated serum ApoE levels are associated with bacterial infections in pediatric patients. J Microbiol Immunol Infect. 2014;47(2):122–129.
59.
WangCWangYWangAFuPYangY. The diagnostic value of apolipoprotein E in pediatric patients with invasive bacterial infections. Clin Biochem. 2012;45(3):215–218.
60.
ChuangKILeungBHsuNHarrisHW. Heparin protects against septic mortality via apoE-antagonism. Am J Surg. 2011;202(3):325–335.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
